CRIS vs BCRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 18, 2026

CRIS

51.3
AI Score
VS
CRIS Wins

BCRX

43.4
AI Score

Investment Advisor Scores

CRIS

51score
Recommendation
HOLD

BCRX

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CRIS BCRX Winner
Net Income -32.78M -15.13M BCRX
Operating Income -21.46M -39.55M CRIS
ROE -698.2% -15.0% BCRX
ROA -172.8% -7.9% BCRX
Total Assets 18.97M 191.49M BCRX
Cash 5.07M 117.78M BCRX
Current Ratio 0.49 2.53 BCRX

Relative Price Performance (Last 90 Days)

CRIS 1M: -67.7% · 3M: +215.2% BCRX 1M: +3.6% · 3M: +16.8%

Current Technical Phase

CRIS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 28

RSI (14): 28.2 · Price: $1.58

BCRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.1% over 20 days), RSI 50

RSI (14): 50.4 · Price: $9.68

Fundamentals Snapshot

Metric CRIS BCRX
Market Cap
Forward P/E -0.3 10.3
Trailing P/E 0.4
Revenue (TTM)
Revenue Growth -0.7% 0.3%
Gross Margin -5.6% 0.8%
Operating Margin -8.3% 0.5%
EPS 3.65 -1.40
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CRIS is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.